-->

| PubMed | eMedicine | OMIM | Google | Google images | Yahoo images | YouTube |

  • Printer friendly version

trisomy 21

Persistent renal lobulation at 8 months in trisomy 21 Clinodactyly and single transverse palmar crease in trisomy (...) Retroesophageal right subclavian artery in trisomy 21 Fifth finger clinodactyly and palmar transverse crease in trisomy (...) Persistence of renal lobulation in trisomy 21 Thick neck in trisomy 21 (fetus 19 weeks) Thick neck in trisomy 21 (fetus 21 weeks) Second, fourth and fifth finger clinodactyly in trisomy 21

Definition: Down syndrome caused by chromosome 21 trisomy is the most common genetic cause of mental retardation in humans. Disruption of the phenotype is thought to be the result of gene-dosage imbalance.

Trisomy 21, also known as Down syndrome (DS), is a complex developmental disorder that affects many organs, including the brain, heart, skeleton and immune system.

A working hypothesis for understanding the consequences of trisomy 21 is that the overexpression of certain genes on chromosome 21, alone or in cooperation, is responsible for the clinical features of DS.

There is now compelling evidence that the protein products of two genes on chromosome 21, Down syndrome candidate region 1 (DSCR1) and dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A), interact functionally, and that their increased dosage cooperatively leads to dysregulation of the signaling pathways that are controlled by the nuclear factor of activated T cells (NFAT) family of transcription factors, with potential consequences for several organs and systems that are affected in DS individuals.

Incidence, 1 in 650-1000 live births

Etiology:

- trisomy 21

  • Meiotic origin >95% maternal, mostly meiosis I - Increased recurrence risk with parental translocation
  • Full trisomy 21: 94%
  • Mosaic trisomy 21: 2.4%
  • Translocation 21: 3.3%

Synopsis

- systemic anomalies

- head and neck anomalies

- cardiovascular anomalies (50%)

  • cardiac malformations
    • atrioventricular canal
  • pulmonary hypertension
  • pulmonary capillary dysplasia
  • pulmonary vascular sclerosis
  • coronary periarteritis nodosa

- digestive anomalies

  • oesophageal atresia (1%)
  • duodenal stenosis/duodenal atresia (30%)
  • imperforate anus and anorectal malformations (2%)
  • Hirschsprung disease (congenital megacolon) (2%)
  • annular pancreas (24%)

- hepatic anomalies

- renal anomalies

- rachis anomalies

  • atlanto-axial instability

- limbs anomalies

- neurological anomalies

- endocrine anomalies

  • hypothyroidism

- hematological anomalies

- autoimmunity

Animal models

- mouse model (16677859)

References

- Prandini P, Deutsch S, Lyle R, Gagnebin M, Delucinge Vivier C, Delorenzi M, Gehrig C, Descombes P, Sherman S, Dagna Bricarelli F, Baldo C, Novelli A, Dallapiccola B, Antonarakis SE. Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet. 2007 Aug;81(2):252-63. PMID: 17668376

Reviews

- de la Luna S, Estivill X. Cooperation to amplify gene-dosage-imbalance effects. Trends Mol Med. 2006 Oct;12(10):451-4. PMID: 16919501

- Antonarakis SE, Epstein CJ. The challenge of Down syndrome. Trends Mol Med. 2006 Oct;12(10):473-9. PMID: 16935027

- Reeves RH. Down syndrome mouse models are looking up. Trends Mol Med. 2006 Jun;12(6):237-40. PMID: 16677859

- Patterson D, Costa AC. Down syndrome and genetics - a case of linked histories. Nat Rev Genet. 2005 Feb;6(2):137-47. PMID: 15640809

- Hitzler JK, Zipursky A. Origins of leukaemia in children with Down syndrome. Nat Rev Cancer. 2005 Jan;5(1):11-20. PMID: 15630411

- Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet. 2004 Oct;5(10):725-38. PMID: 15510164

- Hernandez D, Fisher EM. Down syndrome genetics: unravelling a multifactorial disorder. Hum Mol Genet. 1996;5 Spec No:1411-6. PMID: 8875245